NCT06203158View on ClinicalTrials.gov

Intestinal Epithelial Fucosylation Affects the Efficacy of Ustekinumab in Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

February 10, 2024

Study Completion Date

February 28, 2024

Conditions
IBD
Trial Locations (1)

325000

The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT06203158 - Intestinal Epithelial Fucosylation Affects the Efficacy of Ustekinumab in Crohn's Disease | Biotech Hunter | Biotech Hunter